|
J. Biol. Chem., Vol. 261, Issue 26, 12166-12171, Sep, 1986
Differential and common recognition of the catalytic sites of the cGMP- dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein
DB Glass, HC Cheng, BE Kemp and DA Walsh
Synthetic peptides corresponding to the active domain of the heat- stable
inhibitor protein of cAMP-dependent protein kinase (Cheng, H.- C., Kemp, B.
E., Pearson, R. B., Smith, A. J., Misconi, L., Van Patten, S. M., and
Walsh, D. A. (1986) J. Biol. Chem. 261, 989-992) were tested as inhibitors
of cGMP-dependent protein kinase. The peptides themselves were not
substrates. cGMP-dependent protein kinase activity was assayed using
histone H2B and two synthetic peptide substrates. Consistent with previous
observations of other peptide inhibitors of this enzyme (Glass, D. B.
(1983) Biochem. J. 213, 159-164), the inhibitory peptides had no effect on
the phosphorylation of histone H2B, but they competitively inhibited
cGMP-dependent phosphorylation of the two peptide substrates. The parent
inhibitor peptide, PKI(5-24)amide, and a series of analogs had Ki (or IC50)
values for cGMP-dependent protein kinase in the range of 15-190 microM. In
contrast to their effects on the cAMP-dependent protein kinase, the
inhibitory peptides were substantially less potent with cGMP-dependent
protein kinase, and potency was reduced by the presence of the NH2-terminal
residues (residues 5-13). We conclude that the two protein kinases share a
recognition of the basic amino acid cluster within the pseudosubstrate
region of the peptide, but that the cGMP-dependent protein kinase does not
recognize additional NH2-terminal determinants that make the inhibitor
protein extremely potent toward the cAMP-dependent enzyme. Even- when
tested at high concentrations and with peptide substrates, the native
inhibitor protein did not inhibit cGMP-dependent protein kinase under assay
conditions in which the peptides derived from it were inhibitory. Thus, the
native inhibitor protein appears to have structural features which block
interaction with the cGMP-dependent enzyme and enhance its selectivity for
cAMP-dependent protein kinase.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Yang, C. J. Lee, L. Zhang, M. D. Sans, and D. M. Simeone
Regulation of transforming growth factor {beta}-induced responses by protein kinase A in pancreatic acinar cells
Am J Physiol Gastrointest Liver Physiol,
July 1, 2008;
295(1):
G170 - G178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kaidanovich-Beilin and H. Eldar-Finkelman
Peptides Targeting Protein Kinases: Strategies and Implications.
Physiology,
December 1, 2006;
21(6):
411 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Clarke, M. G. Belvisi, S. J. Smith, E. Hardaker, M. H. Yacoub, K. K. Meja, R. Newton, D. M. Slater, and M. A. Giembycz
Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L238 - L250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Clarke, M. G. Belvisi, E. Hardaker, R. Newton, and M. A. Giembycz
E-Ring 8-Isoprostanes Are Agonists at EP2- and EP4-Prostanoid Receptors on Human Airway Smooth Muscle Cells and Regulate the Release of Colony-Stimulating Factors by Activating cAMP-Dependent Protein Kinase
Mol. Pharmacol.,
February 1, 2005;
67(2):
383 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Meja, M. C. Catley, L. M. Cambridge, P. J. Barnes, H. Lum, R. Newton, and M. A. Giembycz
Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram, Salbutamol, and Prostaglandin E2: A Comparison with H-89
J. Pharmacol. Exp. Ther.,
May 1, 2004;
309(2):
833 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, C. J. Duan, C. Binkley, G. Li, M. D. Uhler, C. D. Logsdon, and D. M. Simeone
A Transforming Growth Factor {beta}-Induced Smad3/Smad4 Complex Directly Activates Protein Kinase A
Mol. Cell. Biol.,
March 1, 2004;
24(5):
2169 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Taylor, R. Ahmed, M. Begley, and M. D. Uhler
Autoinhibition and Isoform-specific Dominant Negative Inhibition of the Type II cGMP-dependent Protein Kinase
J. Biol. Chem.,
September 27, 2002;
277(40):
37242 - 37253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Baek, P. M. Krosky, Z. He, and D. M. Coen
Specific Phosphorylation of Exogenous Protein and Peptide Substrates by the Human Cytomegalovirus UL97 Protein Kinase. IMPORTANCE OF THE P+5 POSITION
J. Biol. Chem.,
August 9, 2002;
277(33):
29593 - 29599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schmidt, J. A. Chiorini, S. Afione, and R. Kotin
Adeno-Associated Virus Type 2 Rep78 Inhibition of PKA and PRKX: Fine Mapping and Analysis of Mechanism
J. Virol.,
February 1, 2002;
76(3):
1033 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Collins and M. D. Uhler
Cyclic AMP- and Cyclic GMP-dependent Protein Kinases Differ in Their Regulation of Cyclic AMP Response Element-dependent Gene Transcription
J. Biol. Chem.,
March 26, 1999;
274(13):
8391 - 8404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang and T. J. Murphy
Inhibition of Cyclic AMP-Dependent Kinase by Expression of a Protein Kinase Inhibitor/Enhanced Green Fluorescent Fusion Protein Attenuates Angiotensin II-Induced Type 1 AT1 Receptor mRNA Down-Regulation in Vascular Smooth Muscle Cells
Mol. Pharmacol.,
September 1, 1998;
54(3):
514 - 524.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. S. C. Johnson, P.-A. Svensson, K. Helou, H. Billig, G. Levan, L. M. S. Carlsson, and B. Carlsson
Characterization and Chromosomal Localization of Rat Scavenger Receptor Class B Type I, a High Density Lipoprotein Receptor with a Putative Leucine Zipper Domain and Peroxisomal Targeting Sequence
Endocrinology,
January 1, 1998;
139(1):
72 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kumar, S. M. Van Patten, and D. A. Walsh
Multiplicity of the beta Form of the cAMP-dependent Protein Kinase Inhibitor Protein Generated by Post-translational Modification and Alternate Translational Initiation
J. Biol. Chem.,
August 8, 1997;
272(32):
20011 - 20020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Collins and M. D. Uhler
Characterization of PKIgamma , a Novel Isoform of the Protein Kinase Inhibitor of cAMP-dependent Protein Kinase
J. Biol. Chem.,
July 18, 1997;
272(29):
18169 - 18178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Y. Anteby, R. D. Johnson, X. Huang, D. M. Nelson, and Y. Sadovsky
Transcriptional Regulation of Prostaglandin-H Synthase-2 Gene in Human Trophoblasts
J. Clin. Endocrinol. Metab.,
July 1, 1997;
82(7):
2289 - 2293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Roberson and J. D. Sweatt
Transient Activation of Cyclic AMP-dependent Protein Kinase during Hippocampal Long-term Potentiation
J. Biol. Chem.,
November 29, 1996;
271(48):
30436 - 30441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Francis, J. A. Smith, J. L. Colbran, K. Grimes, K. A. Walsh, S. Kumar, and J. D. Corbin
Arginine 75in the Pseudosubstrate Sequence of Type Ibeta cGMPdependent Protein Kinase Is Critical for Autoinhibition, Although Autophosphorylated Serine 63Is Outside This Sequence
J. Biol. Chem.,
August 23, 1996;
271(34):
20748 - 20755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Gamm, E. J. Baude, and M. D. Uhler
The Major Catalytic Subunit Isoforms of cAMP-dependent Protein Kinase Have Distinct Biochemical Properties in Vitro and in Vivo
J. Biol. Chem.,
June 28, 1996;
271(26):
15736 - 15742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Habermacher and W. Sale
Regulation of flagellar dynein by an axonemal type-1 phosphatase in Chlamydomonas
J. Cell Sci.,
January 7, 1996;
109(7):
1899 - 1907.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Gamm and M. D. Uhler
Isoform-specific Differences in the Potencies of Murine Protein Kinase Inhibitors Are Due to Nonconserved Amino-terminal Residues
J. Biol. Chem.,
March 31, 1995;
270(13):
7227 - 7232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Burkhardt, M. Glazova, S. Gambaryan, T. Vollkommer, E. Butt, B. Bader, K. Heermeier, T. M. Lincoln, U. Walter, and A. Palmetshofer
KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells
J. Biol. Chem.,
October 20, 2000;
275(43):
33536 - 33541.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|